Predictive Value of Prior Colonization and Antibiotic Use for Third-Generation Cephalosporin-Resistant Enterobacteriaceae Bacteremia in Patients With Sepsis

Wouter C. Rottier*, Yara R. P. Bamberg, J. Wendelien Dorigo-Zetsma, Paul D. van der Linden, Heidi S. M. Ammerlaan, Marc J. M. Bonten

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background. To prevent inappropriate empiric antibiotic treatment in patients with bacteremia caused by third-generation cephalosporin (3GC)-resistant Enterobacteriaceae (3GC-R EB), Dutch guidelines recommend beta-lactam and aminoglycoside combination therapy or carbapenem monotherapy in patients with prior 3GC-R EB colonization and/or recent cephalosporin or fluoroquinolone usage. Positive predictive values (PPVs) of these determinants are unknown.

Methods. We retrospectively studied patients with a clinical infection in whom blood cultures were obtained and empiric therapy with broad-spectrum beta-lactams and/or aminoglycosides and/or fluoroquinolones was started. We determined the PPVs of prior colonization and antibiotic use for 3GC-R EB bacteremia, and the consequences of guideline adherence on appropriateness of empiric treatment.

Results. Of 9422 episodes, 773 (8.2%) were EB bacteremias and 64 (0.7%) were caused by 3GC-R EB. For bacteremia caused by 3GC-R EB, PPVs of prior colonization with 3GC-R EB (90-day window) and prior usage of cephalosporins or fluoroquinolones (30-day window) were 7.4% and 1.3%, respectively, and PPV was 1.8% for the presence of any of these predictors. Adherence to Dutch sepsis guideline recommendations was 27%. Of bacteremia episodes caused by 3GC-R and 3GC-sensitive EB, 56% and 94%, respectively, were initially treated with appropriate antibiotics. Full adherence to guideline recommendations would hardly augment proportions of appropriate therapy, but could considerably increase carbapenem use.

Conclusions. In patients receiving empiric treatment for sepsis, prior colonization with 3GC-R EB and prior antibiotic use have low PPV for infections caused by 3GC-R EB. Strict guideline adherence would unnecessarily stimulate broad-spectrum antibiotic use.

Original languageEnglish
Pages (from-to)1622-1630
Number of pages9
JournalClinical Infectious Diseases
Volume60
Issue number11
DOIs
Publication statusPublished - 1 Jun 2015

Keywords

  • extended-spectrum beta-lactamases
  • empiric antibiotic therapy
  • inappropriate antibiotic therapy
  • risk factors
  • carbapenems
  • LACTAMASE-PRODUCING ENTEROBACTERIACEAE
  • INFECTIOUS-DISEASES
  • ESCHERICHIA-COLI
  • EPIDEMIOLOGY
  • GUIDELINES
  • COMMUNITY
  • THERAPY
  • AMERICA
  • SOCIETY
  • RISK

Fingerprint

Dive into the research topics of 'Predictive Value of Prior Colonization and Antibiotic Use for Third-Generation Cephalosporin-Resistant Enterobacteriaceae Bacteremia in Patients With Sepsis'. Together they form a unique fingerprint.

Cite this